Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted activation ofHNF4α/HGF1/FOXA2reverses hepatic fibrosis via exosome-mediated delivery of CRISPR/dCas9-SAM system
Nianan Luo, Wenjun Zhong, Jiangbin Li, et al.
Nanomedicine (2022) Vol. 17, Iss. 20, pp. 1411-1427
Closed Access | Times Cited: 10

Showing 10 citing articles:

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 34
Ultrasound-Assisted CRISPRi-Exosome for Epigenetic Modification of α-Synuclein Gene in a Mouse Model of Parkinson’s Disease
Weirong Kong, Xin Li, Xiaoyu Guo, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 7837-7851
Closed Access | Times Cited: 12
Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum
Juhyeong Hong, Yong‐Hee Kim
Journal of Controlled Release (2025) Vol. 380, pp. 433-456
Closed Access | Times Cited: 1
CRISPR delivery with extracellular vesicles: Promises and challenges
Anne Højberg Berggreen, J.L. Petersen, Lin Lin, et al.
Journal of Extracellular Biology (2023) Vol. 2, Iss. 9
Open Access | Times Cited: 10
Development of an In Vitro Model of Dysferlinopathy via CRISPR/Cas-Mediated Transcriptional Activation of the DYSF Gene
Ivan A. Yakovlev, Y. S. Slesarenko, И. Г. Старостина, et al.
Cell and Tissue Biology (2025) Vol. 19, Iss. 3, pp. 278-289
Closed Access
Engineered exosomes: a promising drug delivery platform with therapeutic potential
Günter Schwarz, Xiuyan Ren, Wenkun Xie, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Recent advances in the role of exosomes in liver fibrosis
Jiliang Shen, Jiasheng Cao, Mingyu Chen, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 7, pp. 1083-1088
Open Access | Times Cited: 8
Nanogene editing drug delivery systems in the treatment of liver fibrosis
Qun Wang, Siyu Jia, Zihan Wang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Therapeutic insight into the role of nuclear protein HNF4α in liver carcinogenesis
Soumik Das, Harini Ravi, V. Devi Rajeswari, et al.
Advances in protein chemistry and structural biology (2024), pp. 1-37
Closed Access | Times Cited: 1
IFPA Joan Hunt Senior Award in Placentology lecture: Extracellular vesicle signalling and pregnancy
Gregory E. Rice, Carlos Salomón
Placenta (2024) Vol. 157, pp. 5-13
Closed Access | Times Cited: 1
The Role of Extracellular Vesicles in Liver Fibrosis: Friends or Foes?
Xiang Tao, Can Chen, Mei Liu
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2665-2665
Open Access
Page 1

Scroll to top